ACRIVON THERAPEUTICS
ACRV Insider Trades:
all
Powered by unusualwhales.com
Ticker
Trade Date
Filing Date
Name
Title
Code
Security
Amount
Price
Value
Trans.
10b5-1
Director
10% Owner
Mcap/AUM
2025-06-13
2025-06-17
MAGOVCEVIC-LIEBISCH IVANA
A - Grant
Stock Option (Right to Buy)
20,275
$0.00
1
$38.88M
2025-06-13
2025-06-17
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
20,275
$0.00
1
$38.88M
2025-06-13
2025-06-17
TOMSICEK MICHAEL JOHN
A - Grant
Stock Option (Right to Buy)
20,275
$0.00
1
$38.88M
2025-05-21
2025-05-23
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-19,904
$1.00
-19,904
1
$38.88M
2025-05-14
2025-05-16
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-60,257
$1.00
-60,257
2
$38.88M
2025-05-14
2025-05-16
GAMELIN ERICK
Chief Development Officer
F - Tax
Common Stock
-403
$1.00
-403
1
$38.88M
2025-05-14
2025-05-16
PETERSON KATHARINE
Chief Accounting Officer
F - Tax
Common Stock
-99
$1.00
-99
1
$38.88M
2025-04-01
2025-04-03
LEVY ADAM
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
35,209
$0.00
1
$38.88M
2025-04-01
2025-04-03
MILLER MARY
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
15,616
$0.00
1
$38.88M
2025-03-01
2025-03-04
PETERSON KATHARINE
Chief Accounting Officer
A - Grant
Stock Option (Right to Buy)
31,900
$0.00
1
$38.88M
2025-03-01
2025-03-04
CUILLEROT JEAN-MARIE
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
78,078
$0.00
1
$38.88M
2025-03-01
2025-03-04
BLUME-JENSEN PETER
President and CEO
A - Grant
Stock Option (Right to Buy)
531K
$0.00
2
$38.88M
2025-03-01
2025-03-04
DEVROE ERIC
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
141K
$0.00
1
$38.88M
2025-03-01
2025-03-04
GAMELIN ERICK
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
78,078
$0.00
1
$38.88M
2025-03-01
2025-03-04
HOLM-JORGENSEN RASMUS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
109K
$0.00
1
$38.88M
2025-03-01
2025-03-04
MILLER MARY
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
93,693
$0.00
1
$38.88M
2025-02-21
2025-02-25
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-19,904
$6.00
-119K
1
$38.88M
2025-02-14
2025-02-19
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-37,731
$5.00
-189K
2
$38.88M
2025-02-14
2025-02-19
DEVROE ERIC
Chief Operating Officer
F - Tax
Common Stock
-724
$5.00
-3,620
1
$38.88M
2025-02-14
2025-02-19
GAMELIN ERICK
Chief Development Officer
F - Tax
Common Stock
-469
$5.00
-2,345
1
$38.88M
2025-02-14
2025-02-19
HOLM-JORGENSEN RASMUS
Chief Financial Officer
F - Tax
Common Stock
-434
$5.00
-2,170
1
$38.88M
2025-02-14
2025-02-19
PETERSON KATHARINE
Chief Accounting Officer
F - Tax
Common Stock
-116
$5.00
-580
1
$38.88M
2024-03-01
2024-11-27
DEVROE ERIC
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
90,090
$0.00
1
$38.88M
2024-03-01
2024-11-27
GAMELIN ERICK
Chief Development Officer
A - Grant
Stock Option (Right to Buy)
45,045
$0.00
1
$38.88M
2024-03-01
2024-11-27
BLUME-JENSEN PETER
President and CEO
A - Grant
Stock Option (Right to Buy)
315K
$0.00
2
$38.88M
2024-03-01
2024-11-27
HOLM-JORGENSEN RASMUS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
90,090
$0.00
1
$38.88M
2024-03-01
2024-11-27
MILLER MARY
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
67,567
$0.00
1
$38.88M
2024-11-21
2024-11-25
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-19,910
$6.00
-119K
1
$38.88M
2024-11-14
2024-11-18
HOLM-JORGENSEN RASMUS
Chief Financial Officer
F - Tax
Common Stock
-368
$8.00
-2,944
1
$38.88M
2024-11-14
2024-11-18
PETERSON KATHARINE
Chief Accounting Officer
F - Tax
Common Stock
-99
$8.00
-792
1
$38.88M
2024-11-14
2024-11-18
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-60,256
$8.00
-482K
2
$38.88M
2024-11-14
2024-11-18
DEVROE ERIC
Chief Operating Officer
F - Tax
Common Stock
-613
$8.00
-4,904
1
$38.88M
2024-11-14
2024-11-18
GAMELIN ERICK
Chief Development Officer
F - Tax
Common Stock
-402
$8.00
-3,216
1
$38.88M
2024-08-21
2024-08-23
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-79,616
$9.00
-717K
1
$38.88M
2024-08-14
2024-08-16
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-59,765
$7.00
-418K
1
$38.88M
2024-08-14
2024-08-16
DEVROE ERIC
Chief Operating Officer
F - Tax
Common Stock
-613
$7.00
-4,291
1
$38.88M
2024-08-14
2024-08-16
GAMELIN ERICK
Chief Development Officer
F - Tax
Common Stock
-402
$7.00
-2,814
1
$38.88M
2024-08-14
2024-08-16
HOLM-JORGENSEN RASMUS
Chief Financial Officer
F - Tax
Common Stock
-368
$7.00
-2,576
1
$38.88M
2024-08-14
2024-08-16
MASSON KRISTINA
EVP - Business Operations
F - Tax
Common Stock
-490
$7.00
-3,430
1
$38.88M
2024-08-14
2024-08-16
PETERSON KATHARINE
Chief Accounting Officer
F - Tax
Common Stock
-99
$7.00
-693
1
$38.88M
2024-06-20
2024-06-24
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
20,275
$0.00
1
$38.88M
2024-06-20
2024-06-24
TOMSICEK MICHAEL JOHN
A - Grant
Stock Option (Right to Buy)
20,275
$0.00
1
$38.88M
2024-05-17
2024-05-21
DEVROE ERIC
Chief Operating Officer
M - Exercise
Stock Option (Right to Buy)
-10,000
$0.00
1
$38.88M
2024-05-17
2024-05-21
DEVROE ERIC
Chief Operating Officer
M - Exercise
Common Stock
10,000
$1.00
10,000
1
$38.88M
2024-05-14
2024-05-16
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-54,918
$8.00
-439K
1
$38.88M
2024-05-14
2024-05-16
DEVROE ERIC
Chief Operating Officer
F - Tax
Common Stock
-613
$8.00
-4,904
1
$38.88M
2024-05-14
2024-05-16
GAMELIN ERICK
Chief Development Officer
F - Tax
Common Stock
-402
$8.00
-3,216
1
$38.88M
2024-05-14
2024-05-16
HOLM-JORGENSEN RASMUS
Chief Financial Officer
F - Tax
Common Stock
-368
$8.00
-2,944
1
$38.88M
2024-05-14
2024-05-16
MASSON KRISTINA
EVP - Business Operations
F - Tax
Common Stock
-490
$8.00
-3,920
1
$38.88M
2024-05-14
2024-05-16
PETERSON KATHARINE
Chief Accounting Officer
F - Tax
Common Stock
-99
$8.00
-792
1
$38.88M
2024-02-14
2024-02-16
MASSON KRISTINA
EVP - Business Operations
F - Tax
Common Stock
-579
$3.00
-1,737
1
$38.88M
2024-02-14
2024-02-16
GAMELIN ERICK
Chief Development Officer
F - Tax
Common Stock
-468
$3.00
-1,404
1
$38.88M
2024-02-14
2024-02-16
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-41,861
$3.00
-126K
1
$38.88M
2024-02-14
2024-02-16
DEVROE ERIC
Chief Operating Officer
F - Tax
Common Stock
-723
$3.00
-2,169
1
$38.88M
2024-02-14
2024-02-16
HOLM-JORGENSEN RASMUS
Chief Financial Officer
F - Tax
Common Stock
-434
$3.00
-1,302
1
$38.88M
2024-02-08
2024-02-09
MAGOVCEVIC-LIEBISCH IVANA
A - Grant
Stock Option (Right to Buy)
32,500
$0.00
1
$38.88M
2024-01-11
2024-01-16
CUILLEROT JEAN-MARIE
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
99,300
$0.00
1
$38.88M
2023-11-14
2023-11-16
DEVROE ERIC
Chief Operating Officer
F - Tax
Common Stock
-2,450
$5.00
-12,250
1
$38.88M
2023-11-14
2023-11-16
BLUME-JENSEN PETER
President and CEO
F - Tax
Common Stock
-239K
$5.00
-1.20M
1
$38.88M
2023-11-14
2023-11-16
GAMELIN ERICK
Chief Medical Officer
F - Tax
Common Stock
-1,395
$5.00
-6,975
1
$38.88M
2023-11-14
2023-11-16
HOLM-JORGENSEN RASMUS
Chief Financial Officer
F - Tax
Common Stock
-1,470
$5.00
-7,350
1
$38.88M
2023-11-14
2023-11-16
MASSON KRISTINA
EVP - Business Operations
F - Tax
Common Stock
-1,900
$5.00
-9,500
1
$38.88M
2023-09-26
2023-09-28
MILLER MARY
Chief Legal Officer
A - Grant
Stock Option (Right to Buy)
11,576
$0.00
1
$38.88M
2023-06-16
2023-06-20
HOLM-JORGENSEN RASMUS
Chief Financial Officer
M - Exercise
Stock Option (Right to Buy)
-9,500
$0.00
1
$38.88M
2023-06-16
2023-06-20
HOLM-JORGENSEN RASMUS
Chief Financial Officer
M - Exercise
Common Stock
9,500
$4.00
38,000
1
$38.88M
2023-06-05
2023-06-06
DEVROE ERIC
Chief Operating Officer
M - Exercise
Stock Option (Right to Buy)
-9,225
$0.00
1
$38.88M
2023-06-05
2023-06-06
DEVROE ERIC
Chief Operating Officer
M - Exercise
Common Stock
9,225
$1.00
9,225
1
$38.88M
2023-05-31
2023-06-01
BLUME-JENSEN PETER
President and CEO
M - Exercise
Stock Option (Right to Buy)
-33,605
$0.00
1
$38.88M
2023-05-31
2023-06-01
BLUME-JENSEN PETER
President and CEO
M - Exercise
Common Stock
33,605
$4.00
134K
1
$38.88M
2022-11-17
2022-11-21
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Common Stock
888K
1
$38.88M
2022-11-17
2022-11-21
RA CAPITAL MANAGEMENT, L.P.
C - Conversion
Series B Preferred Stock
-3.50M
$0.00
2
$38.88M
2022-11-17
2022-11-21
WELLINGTON BIOMEDICAL INNOVATION MASTER INVESTORS (CAYMAN) L.P.
C - Conversion
Series B Preferred Stock
-2.19M
$0.00
1
$38.88M
2022-11-14
2022-11-16
BLUME-JENSEN PETER
President and CEO
A - Grant
Stock Option (Right to Buy)
260K
$0.00
2
$38.88M
2022-11-14
2022-11-16
DEVROE ERIC
Chief Operating Officer
A - Grant
Stock Option (Right to Buy)
100K
$0.00
1
$38.88M
2022-11-14
2022-11-16
GAMELIN ERICK
Chief Medical Officer
A - Grant
Stock Option (Right to Buy)
60,090
$0.00
1
$38.88M
2022-11-14
2022-11-16
HOLM-JORGENSEN RASMUS
Chief Financial Officer
A - Grant
Stock Option (Right to Buy)
60,090
$0.00
1
$38.88M
2022-11-14
2022-11-16
HOLM-JORGENSEN RASMUS
Chief Financial Officer
A - Grant
Common Stock
20,030
$0.00
1
$38.88M
2022-11-14
2022-11-16
MASSON KRISTINA
EVP - Business Operations
A - Grant
Stock Option (Right to Buy)
260K
$0.00
2
$38.88M
2022-11-14
2022-11-16
MASSON KRISTINA
EVP - Business Operations
A - Grant
Common Stock
1.52M
$0.00
4
$38.88M
2022-11-14
2022-11-16
RA CAPITAL MANAGEMENT, L.P.
A - Grant
Stock Option (Right to Buy)
35,235
$0.00
1
$38.88M
2022-11-14
2022-11-16
TOMSICEK MICHAEL JOHN
A - Grant
Stock Option (Right to Buy)
35,235
$0.00
1
$38.88M